These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25865222)

  • 1. Maintaining immunosuppressive treatment after early allograft nephrectomy does not reduce the risk of anti-HLA allosensitization.
    Del Bello A; Congy-Jolivet N; Kamar N
    Transpl Int; 2015 Sep; 28(9):1113-5. PubMed ID: 25865222
    [No Abstract]   [Full Text] [Related]  

  • 2. Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients.
    Bagnasco SM; Zachary AA; Racusen LC; Arend LJ; Carter-Monroe N; Alachkar N; Nazarian SM; Lonze BE; Montgomery RA; Kraus ES
    Transplantation; 2014 Feb; 97(4):440-5. PubMed ID: 24531821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-human leukocyte antigen immunization after early allograft nephrectomy.
    Del Bello A; Congy N; Sallusto F; Cardeau-Desangles I; Fort M; Esposito L; Guitard J; Cointault O; Lavayssière L; Nogier MB; Game X; Blancher A; Rostaing L; Kamar N
    Transplantation; 2012 May; 93(9):936-41. PubMed ID: 22361471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-binding anti-HLA antibodies and kidney-allograft survival.
    Loupy A; Lefaucheur C; Vernerey D; Prugger C; Duong van Huyen JP; Mooney N; Suberbielle C; Frémeaux-Bacchi V; Méjean A; Desgrandchamps F; Anglicheau D; Nochy D; Charron D; Empana JP; Delahousse M; Legendre C; Glotz D; Hill GS; Zeevi A; Jouven X
    N Engl J Med; 2013 Sep; 369(13):1215-26. PubMed ID: 24066742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics and epitope specificity of anti-human leukocyte antibodies following renal allograft nephrectomy.
    Lachmann N; Schönemann C; El-Awar N; Everly M; Budde K; Terasaki PI; Waiser J
    Nephrol Dial Transplant; 2016 Aug; 31(8):1351-9. PubMed ID: 27190369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch.
    Riella LV; Safa K; Yagan J; Lee B; Azzi J; Najafian N; Abdi R; Milford E; Mah H; Gabardi S; Malek S; Tullius SG; Magee C; Chandraker A
    Transplantation; 2014 Jun; 97(12):1247-52. PubMed ID: 24854670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral Immune Response and Allograft Function in Kidney Transplantation.
    Filippone EJ; Farber JL
    Am J Kidney Dis; 2015 Aug; 66(2):337-47. PubMed ID: 25987262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephron-sparing surgery for malignancies in kidney allografts.
    Varotti G; Bertocchi M; Barabani C; Terulla A; Fontana I
    Transpl Int; 2015 Nov; 28(11):1342-4. PubMed ID: 26190006
    [No Abstract]   [Full Text] [Related]  

  • 9. [Kidney nephrectomy after allograft failure].
    Del Bello A; Rostaing L; Congy-Jolivet N; Sallusto F; Gamé X; Kamar N
    Nephrol Ther; 2013 Jul; 9(4):189-94. PubMed ID: 23410951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
    Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal retransplants: effect of primary allograft nephrectomy on early function, acute rejection and outcome.
    Douzdjian V; Rice JC; Carson RW; Gugliuzza KK; Fish JC
    Clin Transplant; 1996 Apr; 10(2):203-8. PubMed ID: 8664520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune cell function assay does not identify biopsy-proven pediatric renal allograft rejection or infection.
    Ryan CM; Chaudhuri A; Concepcion W; Grimm PC
    Pediatr Transplant; 2014 Aug; 18(5):446-52. PubMed ID: 24930482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of comprehensive assessment of donor specific anti-HLA antibodies in the clinical management of pediatric kidney transplant recipients.
    Gloor JM
    Pediatr Transplant; 2011 Sep; 15(6):557-63. PubMed ID: 21199216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent of nephrectomy, weaning immunosuppression leads to late sensitization after kidney transplant failure.
    Augustine JJ; Woodside KJ; Padiyar A; Sanchez EQ; Hricik DE; Schulak JA
    Transplantation; 2012 Oct; 94(7):738-43. PubMed ID: 22955228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of late allograft nephrectomy.
    Madore F; Hébert MJ; Leblanc M; Girard R; Bastien E; Morin M; Beaudry C; Boucher A; Dandavino R
    Clin Nephrol; 1995 Nov; 44(5):284-9. PubMed ID: 8605707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early protocol biopsies in pediatric renal transplantation: interest for the adaptation of immunosuppression.
    Bruel A; Allain-Launay E; Humbert J; Ryckewaert A; Champion G; Moreau A; Renaudin K; Karam G; Roussey-Kesler G
    Pediatr Transplant; 2014 Mar; 18(2):142-9. PubMed ID: 24341571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
    Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts.
    Barr ML; Cohen DJ; Benvenisty AI; Hardy M; Reemtsma K; Rose EA; Marboe CC; D'Agati V; Suciu-Foca N; Reed E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):262-4. PubMed ID: 8438294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of HLA antibodies on graft survival in long-term renal recipients with functional grafts.
    Zeng Y; Liu Z; Liu Y; Fan Y; Guo Y; Qiu J
    Urol Int; 2014; 92(3):328-33. PubMed ID: 24480999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can withdrawal of CNIs limit the progression of CAN?
    Coccia PA; Ferraris JR
    Pediatr Transplant; 2012 Sep; 16(6):515-7. PubMed ID: 22676491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.